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Abstract 
Background: Neuronostatin, a newly identified peptide, is accepted as an anorexigenic 
peptide since it suppresses food intake when given intracerebroventricularly. Although the 
effect mechanisms of neuronostatin have been shown in different studies, there are no 
reports in the literature describing the mechanisms controlling neuronostatin neurons. In 
this study, we aimed to determine the presence of the ionotropic glutamate receptor 
subunits (iGluRs) in neuronostatin neurons in the periventricular nucleus of the 
hypothalamus.  
Materials and methods: The presence of glutamate receptors in neuronostatin neurons 
was investigated by dual immunohistochemistry. Immunohistochemistry was performed on 
40 µm thick coronal brain sections with antibodies against AMPA (GluA1-4), kainate 
(GluK1/2/3, and GluK5), and NMDA (GluN1 and GluN2A) receptor subunits.  
Results: The results showed that the neuronostatin neurons expressed most of the NMDA 
and non-NMDA receptor subunits. The neuronostatin neurons in the anterior hypothalamic 




GluK5 and GluN1 antibodies. No expression was observed for GluA2, GluA3 and 
GluN2A antibodies.  
Conclusions: For the first time in the literature, our study demonstrated that the 
neuronostatin neurons express glutamate receptor subunits which may form homomeric or 
heteromeric functional receptor complexes. Taken together, these results suggest that 
multiple subunits of iGluRs are responsible for glutamate transmission on neuronostatin 
neurons in the anterior hypothalamic periventricular nucleus.  




Glutamate is the major excitatory amino acid neurotransmitter in the mammalian 
central nervous system (1, 2). Glutamate mediated neurotransmission occurs via 
metabotropic and ionotropic glutamate receptors (13). Ionotropic glutamate receptors are 
classified according to their agonists: N-methyl-D-aspartate (NMDA), α-amino-3-hydroxy-
5-methyl-4-isoazolpropionic acid (AMPA) and 2-carboxy-3-carboxymethyl-4-
isopropenylpyrrolidine (kainate) receptors (13, 16, 31). NMDA receptors are composed of 
subunits named GluN1, GluN2A-D and GluN3A-B (3, 14). These receptors have a critical 
function in excitatory synaptic transmission, plasticity and neurotoxicity (4, 19, 21-23). 
NMDA receptors can participate in very different processes because they have different 
characteristics from AMPA and kainate receptors. In addition to glutamate, an agonist, 
glycine or D-serine, is required for NMDA activation. AMPA receptors are composed of 
four subunits named GluA1-4 (19). Kainate receptors consist of five subunits named 
GluK1-5 (17). While GluK1-3 form functional homomeric receptors, GluK4 and GluK5 
only form functional receptors when combined with one of the other subunits (GluK1-3), 
which generates kainic acid receptors with varying kinetics and agonist affinities (9, 16). 
The other receptors, kainate receptors have presynaptic and postsynaptic localizations 
usually on the same neuron (12). 
Neuronostatin is a newly identified anorexigenic peptide encoded by the 
somatostatin gene (28). Immunohistochemical studies have shown that neuronostatin 
positive neurons are localized in the anterior hypothalamic periventricular nucleus and 




localized in the arcuate nucleus with median eminence. There are fewer and less densely-
marked neuronostatin-expressing cells in the polymorphic layer of the dentate gyrus and 
motor cortex, amygdala and cerebellum (5). These areas where neuronostatin neurons are 
localized in the hypothalamus play a role in the control of food intake (28). Also, 
neuronostatin has regulatory effects on energy consumption (28), cardiovascular system 
(11), and digestive system (27). In the literature, experimental studies investigating central 
regulators (such as glutamate) involved in the control of neuronostatin neurons have not 
been found. 
To better understand glutamatergic function in the neuronostatin neurons localized 
in the anterior hypothalamic periventricular nucleus,it is necessary to determine the 
localization of various iGluR sub-units in neuronostatin neurons. In the present study, we 
examined the cellular localization of protein expression of AMPA (GluA1, GluA2, GluA3, 
and GluA4), kainate (GluK1/2/3 and GluK5), and NMDA (GluN1 and GluN2A) receptor 
subunits in the neuronostatin neurons in the periventricular nucleus of the hypothalamus by 
immunofluorescence. 
 
MATERIALS AND METHODS 
Animals 
All animal experiments were carried out under the National Institute of Health 
Guide for the Care and Use of Laboratory Animals and approved by the Experimental 
Ethical Committee of Bursa Uludag University. 60-day-old male Sprague-Dawley rats 
(200-250 g) (n=10) were used in this study. The rats were maintained at the Bursa Uludag 
University Experimental Animals Breeding and Research Center and were housed two per 
cage in a temperature-controlled environment (21°C) with a 12:12-hour light/dark cycle.  
The animals were allowed to access food and water ad libitum. All the experiments were 
carried out between 9:00 am and 11:00 am. 
 
Tissue preparation 
The animals were deeply anesthetized and fixed by trans-cardiac perfusion with 4% 
paraformaldehyde in phosphate buffer, pH 7.4 (300 mL per animal). Brains and brainstems 
were carefully removed and post-fixed overnight in the same fixative. Forty-micrometer-




into Tris-HCl buffer (0.05 M, pH 7.6). The sections were kept in the cryoprotectant 
solution at -20°C until use. 
 
Immunohistochemistry 
Tris-HCl buffer was used for all washing steps. Blocking buffer (10% normal horse 
serum, 0.2% triton X-100, and 0.1% sodium azide in Tris-HCl buffer) was used for 
incubations to prevent non-specific binding and to dilute the antibodies. All incubation 
steps were carried out on an orbital shaker with appropriate agitation. 
Free-floating sections were equilibrated to room temperature and washed 3 times in 
Tris-HCl buffer to remove cryoprotectant and blocked in blocking buffer for 2 hours. 
Following the washing step, tissues were incubated in preheated Antigen Retrieval (AR) 
solution (final solution temperature 73-75°C) for 30 minutes. 50 mM trisodium citrate 
buffer (pH 6, for neuronostatin, GluK1/2/3 and GluA4) or 1 mM EDTA solution (pH 8, for 
GluN1 and GluN2A) was used in the AR process. The sections were washed three times. 
Tissues were treated with 3% H2O2 to quench endogenous peroxidase, washed three times 
and blocked with 10% normal horse serum for 2 hours. The sections were incubated in 
rabbit anti-neuronostatin (1/4000 dilution, H-060-50, Phoenix Pharmaceuticals, Inc., USA) 
and mouse anti-GluA1 (1/500 dilution, AM60040PU-N, Acris, USA), mouse anti-GluA2 
(1/500 dilution, MAB397, Millipore, USA), mouse anti-GluA3 (1/250 dilution, MAB5416, 
Millipore, USA), goat anti-GluA4 (1/250 dilution, LS-B3606, LifeSpan BioSciences, Inc., 
USA), mouse anti-GluK1/2/3 IgM (1/500 dilution, MAB379, Chemican Int., USA), goat 
anti-GluK5 (1/250 dilution, sc-8915, Santa Cruz Biotechnology, Inc., USA), mouse anti-
GluN1 (1/500 dilution, 556308, BD Pharmingen, USA), and mouse anti-GluN2A (1/3000 
dilution, H-060-50, Millipore, USA). The washed sections were processed with donkey 
anti-goat IgG-Alexa Fluor (1/500 dilution), donkey anti-mouse IgG Alexa-Fluor (1/500 
dilution), donkey anti-mouse IgM-biotin-conjugate (1/200 dilution), donkey anti-rabbit 
IgG-Alexa-Fluor 488 (1/500 dilution) and streptavidin-TR (1/100 dilution) for 2 hours. 
After washes, the sections were mounted on glass slides, dried and coverslipped with 
Prolong gold antifade medium. 
Neuronostatin antibodies used in this study have been used in many reports in the 








Sections were analyzed and photographed with Olympus BX-50 photomicroscope 
attached to a CCD camera (Olympus DP71, CCD color camera, 1.5 million pixels, 
Olympus Corporation, Japan). Sections between the coordinates determined according to 
the rat brain atlas (bregma-0.24 mm to -3.60 mm for periventricular nucleus) were used for 
single and double immunohistochemical labeling (24). Cross-sections were taken at 5 
different levels at the same coordinate and an equal distance for each animal. 
Immunofluorescent staining intensities of neuronostatin neurons co-localized with Kainic 
acid, AMPA and NMDA receptor subunits in the anterior hypothalamic periventricular 
nucleus were graded by the following scale: ‘+’ was used for a small number of double 
immunoreactive neuronostatin neurons, ‘++’ for a moderate number of double 
immunoreactive neuronostatin neurons, and ‘+++’ for a high number of double 
immunoreactive neuronostatin neurons. 
 
RESULTS 
The results showed that iGluRs subunits were expressed in neuronostatin neurons 
localized in the anterior hypothalamic periventricular nucleus. Specific staining was 
localized in neuronal perikarya. The number of stained neuronostatin neurons changed 
depending on the type of iGluRs subunits. The neuronostatin neurons in the anterior 
hypothalamic periventricular nucleus were particularly immunopositive for GluA1, GluA4, 
GluK1/2/3, GluK5 and GluN1 antibodies. No expression was observed for GluA2, GluA3 
and GluN2A antibodies. The highest expression was detected for GluN1-positive 
neuronostatin neurons.  
Neuronostatin protein positivity was visualized by green reaction product with a 
fluorochrome (Alexa 488) (Fig. 1A) and glutamate receptor subunit protein positivity was 
labeled by red fluorochromes (Alexa 594 or streptavidin-conjugated Texas-Red) (Fig. 1B) 
in the cytoplasm. In digitally overlapped images, neurons expressing both proteins were 





The expression of kainic acid receptor subunits in neuronostatin neurons (GluK1-3 
and GluK5) 
Dual immunofluorescence studies showed that GluK1, GluK2, GluK3 and GluK5 
positive neuronostatin neurons were expressed in the anterior hypothalamic periventricular 
nucleus. However, a small number of GluK1, GluK2, GluK3 (Fig. 2A) and GluK5-positive 
neuronostatin neurons (Fig. 2B) was observed in the anterior hypothalamic periventricular 
nucleus (Table 1).  
 
The expression of AMPA receptor subunits in neuronostatin neurons (GluA1-4) 
GluA1 (Fig. 3A) and GluA4 subunit protein (Fig. 3B) from the AMPA receptor 
family were co-expressed in neuronostatin neurons. However, GluA2 and GluA3 subunit 
proteins were not expressed in neuronostatin neurons.  
GluA1, GluA4 and neuronostatin neurons were expressed in the anterior hypothalamic 
periventricular nucleus. A moderate number of neuronostatin neurons expressing GluA1 
and GluA4 was detected in the anterior hypothalamic periventricular nucleus (Table 1). 
 
The expression of NMDA receptor subunits in neuronostatin neurons (GluN1 and 
GluN2A) 
GluN1-positive neuronostatin neurons were observed in the anterior hypothalamic 
periventricular nucleus (Fig. 3C). However, no expression of GluN2A subunit protein was 
detected in neuronostatin neurons. The number of GluN1-positive neuronostatin neurons 
varied from moderate to high (Table 1). 
 
DISCUSSION 
The present study showed that both NMDA and non-NMDA glutamate receptor 
proteins were synthesized by neuronostatin neurons. Our results indicated that 
neuronostatin neurons express iGluRs subunits in varying quantities and intensities. To the 
best of our knowledge, this is the first descriptive study on the differential expression 
pattern of iGluRs in the neuronostatin neurons localized in the anterior hypothalamic 
periventricular nucleus. GluA1, GluA4, GluK1/2/3, GluK5 and GluN1 receptor proteins 
were expressed in neuronostatin neurons, but no immunoreactivity indicating the presence 





Localization of ionotropic glutamate receptors in the anterior hypothalamic 
periventricular nucleus 
Studies showing the distribution at mRNA and protein levels of glutamate receptors 
in the central nervous system and hypothalamus are available in the literature (7, 8, 18, 25, 
26, 29). In studies on immunohistochemistry and in-situ hybridization in the anterior 
hypothalamic periventricular nucleus, GluA1 and GluA2 proteins from the AMPA receptor 
family were moderately high in density; GluA3 and GluA4 have been reported to be 
expressed at low intensity (18, 29). In another in-situ hybridization study, the presence at 
the mRNA level of kainate receptor subunits was determined in the anterior hypothalamic 
periventricular nucleus and it was shown that GluK5 expression was high and that other 
subunits (GluK1, GluK2 and GluK3) were expressed at low-medium density (7). In the 
same study, mRNA signals of NMDA receptor subunits were also determined and the most 
intense signal was shown to belong to GluN2A. mRNA signals of GluN1, GluN2B and 
GluN2D subunits were reported to be moderate, and at low density for GluN2C (7). 
Results of the present study show that some NMDA and non-NMDA glutamate receptor 
signals belong to neuronostatin neurons in the anterior hypothalamic periventricular 
nucleus. 
 
Kainic acid receptor subunits in neuronostatin neurons (GluK1-3 and GluK5) 
Glutamate receptor subunits combine to form functional receptor complexes. These 
receptor complexes may be homomeric or heteromeric. Homomeric ion channels are 
formed by combining the same subunits, heteromeric functional ion channels are formed 
by combining different subunits (10, 15, 19). The present study demonstrated that 
neuronostatin neurons express receptor subunit proteins of the kainate receptor family. 
The present study suggests two ideas about the kainate receptor proteins expressed in 
neuronostatin neurons: 1) The GluK5 subunit cannot form a stand-alone channel; it can 
form a functional heteromeric kainate receptor complex combined with one of the GluK1, 
GluK2 or GluK3 subunits; 2) GluK1, GluK2 or GluK3, which are low-affinity kainate 
receptor subunits, may form functional homomeric kainate receptor complexes. 
 




AMPA receptor complexes may form homomeric ion channels but are mostly 
present in the form of heteromers (10, 19). GluA1 and GluA4 subunits, which were 
determined to be expressed in neuronostatin neurons, were thought to form functional 
cation channels either individually or together. The results of the present study showed that 
the activating effect of glutamate on neuronostatin neurons was mediated by AMPA-
selective ionotropic glutamate receptors along with kainate receptors. 
 
NMDA receptor subunits in neuronostatin neurons (GluN1 ve GluN2A) 
NMDA receptor subunits can only form functional receptor complexes of 
heteromeric structure (23). The essential subunit of NMDA receptor complexes is GluN1 
(15). The present study showed that GluN1, a NMDA receptor subunit protein, was 
expressed in neuronostatin neurons. 
Although GluN2A immunoreactivity was not determined in neuronostatin neurons, 
they were still thought to carry functional NMDA-selective glutamate receptors. This is 
because 1) Expression of GluN1, the indispensable subunit of NMDA receptor complexes, 
was positive in neuronostatin neurons: 2) The GluN1 subunit forms functional receptor 
channels with other types of GluN2. In the present study, the expressions of GluN2B, 
GluN2C and GluN2D subunits in neuronostatin neurons were not investigated. Even so, 
the GluN2B, C and D receptor types are expressed in the anterior hypothalamic 
periventricular nucleus. The results suggest that neuronostatin neurons localized in the 
anterior hypothalamic periventricular nucleus may also express these receptor types and 
therefore may be regulated by NMDA receptors.  
For the first time in the literature, our study demonstrated that the neuronostatin 
neurons express glutamate receptor subunits which may form homomeric or heteromeric 
functional receptor complexes. 
 
CONCLUSIONS 
As conclusion, glutamate plays an effective role in regulating the functions of 
neurons synthesizing neuronostatin and glutamate shows its effectiveness through NMDA 
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Table I. The distribution of the staining intensity of ionotropic glutamate receptor subunits 
in neuronostatin neurons localized in the anterior hypothalamic periventricular nucleus. 
 
 
Figure 1. Evaluation of dual immunohistochemical markings. A: Neurons expressing the 
peptide labeled with green fluorochrome. B: Neurons expressing glutamate receptor subunit 
protein labeled with red fluorochrome. C: Neurons expressing the glutamate receptor subunit 




GluK1/2/3 GluK5 GluA1 GluA2 GluA3 GluA4 GluN1 GluN2A  





Figure 2. Immunofluorescence image of GluK1/2/3-positive neuronostatin neurons in the 
anterior hypothalamic periventricular nucleus (A). Immunofluorescence image of GluK5-
positive neuronostatin neurons in the anterior hypothalamic periventricular nucleus (B). 






Figure 3. Immunofluorescence image of GluA1-positive neuronostatin neurons in the 
anterior hypothalamic periventricular nucleus (A). Immunofluorescence image of GluA4-
positive neuronostatin neurons in the anterior hypothalamic periventricular nucleus 
(B).Immunofluorescence image of GluN1-positive neuronostatin neurons in the anterior 
hypothalamic periventricular nucleus (C). Neurons co-expressing both proteins (white 
arrowhead), only GluA1-positive neurons, only GluA4-positive neurons,  only GluN1-
positive neurons (yellow arrowhead) and only neuronostatin-immunoreactive neurons (blue 
arrowhead). 
